Harbor Capital Advisors, Inc. Legend Biotech Corp Transaction History
Harbor Capital Advisors, Inc.
- $1.31 Billion
- Q2 2024
A detailed history of Harbor Capital Advisors, Inc. transactions in Legend Biotech Corp stock. As of the latest transaction made, Harbor Capital Advisors, Inc. holds 10,729 shares of LEGN stock, worth $501,151. This represents 0.04% of its overall portfolio holdings.
Number of Shares
10,729
Previous 7,904
35.74%
Holding current value
$501,151
Previous $443,000
7.22%
% of portfolio
0.04%
Previous 0.06%
Shares
5 transactions
Others Institutions Holding LEGN
# of Institutions
213Shares Held
63.6MCall Options Held
1.09MPut Options Held
525K-
Price T Rowe Associates Inc Baltimore, MD10.9MShares$511 Million0.08% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$280 Million7.45% of portfolio
-
Black Rock Inc. New York, NY5.38MShares$251 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA2.61MShares$122 Million0.03% of portfolio
-
Capital World Investors Los Angeles, CA2.39MShares$111 Million0.02% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $7.82B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...